amifostine
Showing 1 - 25 of 103
Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone
Withdrawn
- Drug/Agent Toxicity by Tissue/Organ
- +3 more
- amifostine trihydrate
- +2 more
-
Chicago, Illinois
- +3 more
Jan 31, 2023
Oral Mucositis, Stomatitis Trial (Amifostine)
Withdrawn
- Oral Mucositis
- Stomatitis
- Amifostine
- (no location specified)
Nov 9, 2021
Solid Tumors, Brain Tumors Trial in Cincinnati (Amifostine)
Terminated
- Solid Tumors
- Brain Tumors
- Amifostine
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 29, 2021
Breast Cancer Trial in Duarte (biological, drug, procedure)
Active, not recruiting
- Breast Cancer
- filgrastim
- +5 more
-
Duarte, CaliforniaCancer Center and Beckman Research Institute, City of Hope
Feb 17, 2022
Head Neck Cancer Trial in Philadelphia (drug, procedure, radiation)
Terminated
- Head and Neck Cancer
- amifostine trihydrate
- +4 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Cancer Center
Jan 11, 2022
Lung Cancer Trial in Houston (Cisplatin, Amifostine)
Active, not recruiting
- Lung Cancer
- Cisplatin
- Amifostine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 29, 2022
Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)
Withdrawn
- Leukemia
- recombinant interferon alfa
- +7 more
-
Chicago, Illinois
- +3 more
Oct 6, 2021
Colorectal Cancer Trial in Los Angeles, Rancho Cucamonga (amifostine trihydrate, irinotecan HCl)
Completed
- Colorectal Cancer
- amifostine trihydrate
- irinotecan hydrochloride
-
Los Angeles, California
- +1 more
Jul 30, 2020
AminoMedixTM for Kidney Protection During Radionuclide Therapy
Completed
- Radiation Nephropathy
- (no location specified)
Mar 22, 2023
Locally Advanced Rectal Cancer Trial in Shanghai (Radiation, Capecitabine, Irinotecan)
Unknown status
- Locally Advanced Rectal Cancer
- Radiation
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 19, 2019
Cancer of Head and Neck, Head Cancer, Head Neck Cancer Trial in Birmingham (Cisplatin, Docetaxel, Radiotherapy)
Completed
- Cancer of Head and Neck
- +4 more
- Cisplatin
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 2, 2019
MDS Trial in Houston (Amifostine Trihydrate)
Completed
- Myelodysplastic Syndromes
- Amifostine Trihydrate
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Oct 23, 2018
Nausea Gravidarum, Vomiting of Pregnancy, Pregnancy Related Trial in Kocaeli (Band-aid application)
Recruiting
- Nausea Gravidarum
- +3 more
- Band-aid application
-
Kocaeli, Kocaeli̇, TurkeyYeni Yalı Aile Sağlığı Merkezi
Mar 28, 2023
Oral Mucositis Trial in Istanbul (coconut oil)
Not yet recruiting
- Oral Mucositis
- coconut oil
-
Istanbul, TurkeyBaşakşehir Çam and Sakura City Hospital
May 8, 2023
Breast Cancer Trial in France, Monaco (drug, other, radiation)
Recruiting
- Breast Cancer
- EXPERIMENTAL ARM
- +2 more
-
Mougins, Alpes-Maritimes, France
- +6 more
Jan 7, 2022
Chemo-induced Peripheral Neuropathy Trial (Curcumin, Paclitaxel)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Curcumin
- Paclitaxel
- (no location specified)
Jul 21, 2023
Radiation Dermatitis Trial in Taichung (Radiation Care Gel)
Recruiting
- Radiation Dermatitis
- Radiation Care Gel
-
Taichung, TaiwanChina Medical University Hospital
Aug 4, 2021
Diarrhea, Cancer Trial in Bratislava (PROBIO-FIX INUM®, Placebo)
Completed
- Diarrhea
- Cancer
- Probio-Tec® BG-VCap-6.5
- Placebo
-
Bratislava, SlovakiaNational Cancer Institute
Dec 12, 2022
Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Breast
Completed
- Breast Cancer Female
- Neuropathic Pain
-
Thane, Maharashtra, IndiaAnuja Bidkar
Oct 10, 2020
Oral Mucositis (Ulcerative) Trial in Navi Mumbai (Curcumin Lozenges, Placebo Lozenges)
Recruiting
- Oral Mucositis (Ulcerative)
- Curcumin Lozenges
- Placebo Lozenges
-
Navi Mumbai, Maharashtra, IndiaTata Memorial Centre
May 20, 2021
Nasopharyngeal Tumors, Salivary Gland Diseases, Bone Marrow Diseases Trial in Guangzhou (Amifostine every-other-day regimen,
Unknown status
- Nasopharyngeal Neoplasms
- +3 more
- Amifostine every-other-day regimen
- Amifostine everyday regimen
-
Guangzhou, Guangdong, China
- +6 more
Jul 11, 2017
Dysphagia, Head Neck Cancer, Mucositis Trial in Nashville (behavioral, drug, procedure)
Terminated
- Dysphagia
- +3 more
- exercise intervention
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
May 28, 2017
Trigeminal Neuralgia Trial in Stanford (Amifostine, CyberKnife stereotactic radiosurgery)
Terminated
- Trigeminal Neuralgia
- Amifostine
- CyberKnife stereotactic radiosurgery
-
Stanford, CaliforniaStanford University School of Medicine
Feb 16, 2017